178 related articles for article (PubMed ID: 25522256)
1. Lipocalin-2 and matrix metalloproteinase-9 expression in high-grade endometrial cancer and their prognostic value.
Srdelić Mihalj S; Kuzmić-Prusac I; Zekić-Tomaš S; Šamija-Projić I; Čapkun V
Histopathology; 2015 Aug; 67(2):206-15. PubMed ID: 25522256
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of a specific receptor for lipocalin2 (solute carrier family 22 member 17, SLC22A17) and its prognostic significance in endometrial carcinoma.
Miyamoto T; Asaka R; Suzuki A; Takatsu A; Kashima H; Shiozawa T
Exp Mol Pathol; 2011 Oct; 91(2):563-8. PubMed ID: 21763306
[TBL] [Abstract][Full Text] [Related]
3. Lipocalin 2 expression is associated with aggressive features of endometrial cancer.
Mannelqvist M; Stefansson IM; Wik E; Kusonmano K; Raeder MB; Øyan AM; Kalland KH; Moses MA; Salvesen HB; Akslen LA
BMC Cancer; 2012 May; 12():169. PubMed ID: 22559235
[TBL] [Abstract][Full Text] [Related]
4. MAGE-A4 and MAGE-A1 Immunohistochemical Expression in High-grade Endometrial Cancer.
Srdelić S; Kuzmić-Prusac I; Spagnoli GC; Juretić A; Čapkun V
Int J Gynecol Pathol; 2019 Jan; 38(1):59-65. PubMed ID: 29140883
[TBL] [Abstract][Full Text] [Related]
5. Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer.
Kubben FJ; Sier CF; Hawinkels LJ; Tschesche H; van Duijn W; Zuidwijk K; van der Reijden JJ; Hanemaaijer R; Griffioen G; Lamers CB; Verspaget HW
Eur J Cancer; 2007 Aug; 43(12):1869-76. PubMed ID: 17604154
[TBL] [Abstract][Full Text] [Related]
6. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of neutrophil gelatinase-associated lipocalin in colorectal cancer predicts poor patient survival.
Maier HT; Aigner F; Trenkwalder B; Zitt M; Vallant N; Perathoner A; Margreiter C; Moser P; Pratschke J; Amberger A
World J Surg; 2014 Aug; 38(8):2160-7. PubMed ID: 24682311
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of special AT-rich sequence-binding protein 1 in endometrial cancer: a clinicopathologic study.
Zhang Y; Wang L; Liu Y; Meng F; Wang S; Shang P; Gao Y; Chen X
Int J Gynecol Cancer; 2015 Jan; 25(1):4-11. PubMed ID: 25347096
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil gelatinase-associated lipocalin and its receptor: independent prognostic factors of oesophageal squamous cell carcinoma.
Du ZP; Lv Z; Wu BL; Wu ZY; Shen JH; Wu JY; Xu XE; Huang Q; Shen J; Chen HB; Li EM; Xu LY
J Clin Pathol; 2011 Jan; 64(1):69-74. PubMed ID: 21109701
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in stage I colorectal carcinoma.
Barresi V; Reggiani-Bonetti L; Di Gregorio C; Vitarelli E; Ponz De Leon M; Barresi G
Pathol Res Pract; 2011 Aug; 207(8):479-86. PubMed ID: 21726963
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemically detected high expression of matrix metalloproteinase-2 as predictor of poor prognosis in Duke's B colon cancer.
Sundov Z; Tomić S; Vilović K; Kunac N; Kalebić M; Bezić J
Croat Med J; 2008 Oct; 49(5):636-42. PubMed ID: 18925697
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil gelatinase-associated lipocalin is expressed in osteoarthritis and forms a complex with matrix metalloproteinase 9.
Gupta K; Shukla M; Cowland JB; Malemud CJ; Haqqi TM
Arthritis Rheum; 2007 Oct; 56(10):3326-35. PubMed ID: 17907186
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in lung adenocarcinoma.
Ruiz-Morales JM; Dorantes-Heredia R; Arrieta O; Chávez-Tapia NC; Motola-Kuba D
Tumour Biol; 2015 May; 36(5):3601-10. PubMed ID: 25542236
[TBL] [Abstract][Full Text] [Related]
14. Gelatinases A and B (MMP-2 and MMP-9) in endometrial cancer-MMP-9 correlates to the grade and the stage.
Aglund K; Rauvala M; Puistola U; Angström T; Turpeenniemi-Hujanen T; Zackrisson B; Stendahl U
Gynecol Oncol; 2004 Sep; 94(3):699-704. PubMed ID: 15350361
[TBL] [Abstract][Full Text] [Related]
15. Lipocalin2 enhances the matrix metalloproteinase-9 activity and invasion of extravillous trophoblasts under hypoxia.
Kobara H; Miyamoto T; Suzuki A; Asaka R; Yamada Y; Ishikawa K; Kikuchi N; Ohira S; Shiozawa T
Placenta; 2013 Nov; 34(11):1036-43. PubMed ID: 23972287
[TBL] [Abstract][Full Text] [Related]
16. L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation.
Zeimet AG; Reimer D; Huszar M; Winterhoff B; Puistola U; Azim SA; Müller-Holzner E; Ben-Arie A; van Kempen LC; Petru E; Jahn S; Geels YP; Massuger LF; Amant F; Polterauer S; Lappi-Blanco E; Bulten J; Meuter A; Tanouye S; Oppelt P; Stroh-Weigert M; Reinthaller A; Mariani A; Hackl W; Netzer M; Schirmer U; Vergote I; Altevogt P; Marth C; Fogel M
J Natl Cancer Inst; 2013 Aug; 105(15):1142-50. PubMed ID: 23781004
[TBL] [Abstract][Full Text] [Related]
17. Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas.
Salvesen HB; Iversen OE; Akslen LA
Clin Cancer Res; 1998 Nov; 4(11):2779-85. PubMed ID: 9829742
[TBL] [Abstract][Full Text] [Related]
18. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
19. Temporal pattern of recurrence of stage I endometrial cancer in relation to histological risk factors.
Ben Arie A; Lavie O; Gdalevich M; Voldarsky M; Barak F; Schneider D; Levy T; Anteby E; Gemer O
Eur J Surg Oncol; 2012 Feb; 38(2):166-9. PubMed ID: 22056646
[TBL] [Abstract][Full Text] [Related]
20. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
